EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases

Yanyu Bao, Guoying Miao, Nannan He, Xingting Bao, Zheng Shi, Cuilan Hu, Xiongxiong Liu iD, Bing Wang iD, Chao Sun iD

Biology · 20.01.2026 · 15 (2) · 189

DOI: 10.3390/biology15020189 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 20.01.2026. Verfasst von Yanyu Bao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Top Talents Project of Gansu Province, the Science and Technology Innovation Talent Program of Chengguan District, the Natural Science Foundation of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is a key early pathological process in neurodegenerative diseases (NDs), leading to oxidative stress, impaired energy metabolism, and neuronal apoptosis prior to the onset of clinical symptoms. Although mitochondria represent important therapeutic targets, effective interventions targeting mitochondrial function remain limited. This review summarizes current evidence regarding the mechanisms by which melatonin protects mitochondria and evaluates its therapeutic relevance, with a primary focus on Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease—the major protagonists of NDs—while briefly covering other NDs such as amyotrophic lateral sclerosis, multiple sclerosis, and prion diseases. Melatonin selectively accumulates in neuronal mitochondria and exerts neuroprotection through multiple pathways: (1) direct scavenging of reactive oxygen species (ROS); (2) transcriptional activation of antioxidant defenses via the SIRT3 and Nrf2 pathways; (3) regulation of mitochondrial dynamics through DRP1 and OPA1; and (4) promotion of PINK1- and Parkin-mediated mitophagy. Additionally, melatonin exhibits context-dependent pleiotropy: under conditions of mild mitochondrial stress, it restores mitochondrial homeostasis; under conditions of severe mitochondrial damage, it promotes pro-survival autophagy by inhibiting the PI3K/AKT/mTOR pathway, thereby conferring stage-specific therapeutic advantages. Overall, melatonin offers a sophisticated mitochondria-targeting strategy for the treatment of NDs. However, successful clinical translation requires clarification of receptor-dependent signaling pathways, development of standardized dosing strategies, and validation in large-scale randomized controlled trials.

Schlagwörter

Stichwörter der Autor:innen

melatoninmitochondrial dysfunctionmitochondrial quality controlneurodegenerative diseasesoxidative stress

Autor:innen und Institutionen

  • Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
  • State Key Laboratory of Heavy Ion Science and Technology, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Gansu Provincial Maternity and Child-Care Hospital/Gansu Provincial Central Hospital, Lanzhou 730000, China.
  • Department of Critical Care Medicine, The Second Hospital of Lanzhou University, Lanzhou 730000, China.
  • Medical College, Northwest Minzu University, Lanzhou 730000, China.

ORCID-Profile: Xiongxiong Liu, Bing Wang, Chao Sun

Förderung

  • the Top Talents Project of Gansu Province
  • the Science and Technology Innovation Talent Program of Chengguan District
  • the Natural Science Foundation of Gansu Province
  • the Young Scientists Fund of the National Natural Science Foundation of China
  • the Longyuan Youth Talent Program of Gansu Province

Zitieren

APA

Bao, Y., Miao, G., He, N., Bao, X., Shi, Z., Hu, C., Liu, X., Wang, B., & Sun, C. (2026). Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases. Biology, 15(2), 189. https://doi.org/10.3390/biology15020189

Vancouver

Bao Y, Miao G, He N, Bao X, Shi Z, Hu C, et al. Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases. Biology. 2026;15(2):189. doi:10.3390/biology15020189

BibTeX
@article{Bao2026,
  author = {Bao, Yanyu and Miao, Guoying and He, Nannan and Bao, Xingting and Shi, Zheng and Hu, Cuilan and Liu, Xiongxiong and Wang, Bing and Sun, Chao},
  title = {Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases},
  journal = {Biology},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {189},
  doi = {10.3390/biology15020189}
}
Kostenlos starten →